Time flies and years go by. As we approach the end of 2023, we would like to share with you Rocgene’s journey throughout this year.

⭐ Product Strength ⭐

Seeking Truth and Being Practical, Innovating Without End

This year, we launched nearly 100 new products including instruments and reagents, covering scientific research, molecular diagnostics, biopharmaceuticals, and animal healthcare. Among them, Archimed Mini 16 and iFIND successively obtained Class III National Medical Device Registration Certificates. Archimed X4/X6 and Archimed Mini 16 received dual certifications from the US FDA and UK UKCA, reflecting market recognition of Rocgene’s products at home and abroad, and further enhancing our core competitiveness in the molecular diagnostics market.

⭐ Strategic Cooperation ⭐

Win-Win Collaboration, Hand in Hand for Mutual Success

March

Leaders from the Health and Pharmaceutical Innovation Branch of the China Invention Association and the Medical and Health Science and Technology Development Center of the National Health Commission visited Rocgene. The two sides exchanged views on strategic planning, technological innovation, and business strategies, and reached broad consensus.

May

Hetang Shenghua and Rocgene signed a strategic cooperation agreement. Both parties will give full play to their respective advantages in biomedicine to provide customers with more efficient and cost-effective production and testing services for cell and gene therapy drugs.

June

At the 15th China Bioindustry Conference co-hosted by the People’s Government of Hubei Province, 18 national-level associations including the Chinese Society of Biotechnology, and China Science and Technology News, Mr. Dai Tao, Deputy General Manager of Rocgene, signed major projects on behalf of the company.

⭐ Industry Exchange ⭐

Uniting for Strength, Seeking Common Development

This year, Rocgene participated in 21 major IVD industry exhibitions and organized more than 100 online and offline customer training sessions.

⭐ Corporate Honors ⭐

Perseverance, Scaling New Heights

Rocgene received the “Innovative Small and Medium-sized Enterprise” certificate

Rocgene was listed as a “Specialized, Sophisticated, Unique, and New” Enterprise in Beijing

Rocgene was honored to participate in the formulation of GB/T 42753-2023, China’s first national standard for real-time fluorescent quantitative PCR instruments

Rocgene won the first place in the online voting “My Favorite Domestic Brand” for PCR instruments sponsored by Yuanyi Capital

Rocgene became a council member of the Beijing Tuberculosis Diagnosis and Treatment Technology Innovation Alliance

05

A Bright Journey, A Unique Landscape

This year, Rocgene moved to a new headquarters. The 10,000-square-meter Beijing headquarters integrates R&D center, pilot production center, quality center, marketing center, finance center, supply chain center, and operation management center. With a brighter and more comfortable working environment, cleaner and standardized laboratories, and clearer division of labor, we will surely scale new heights and achieve breakthroughs one after another!

A new year, a new starting point.

The journey continues, and the struggle never stops.

We will keep forging ahead,

answer with hard work,

deliver with achievements,

and shine through endeavor!